Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating fibroblast growth factor 21 (FGF-21) deficiency

Method of treating fibroblast growth factor 21 (FGF-21) deficiency

US Patent 10874714 · Granted Dec 29, 2020

Estimated economic value: $12,747,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glycolipids as treatment for disease2020
Mutant endoglycoceramidases with enhanced synthetic activity2019
Process for the production of purified cytidinemonophosphate-sialic acid-polyalk2016
Remodeling and glycopegylation of fibroblast growth factor (FGF)2015
Glycosylation of peptides via O-linked glycosylation sequences2015
Compositions and methods for the preparation of protease resistant human growth 2015
Conjugated factor VIII molecules2015
Mutant endoglycoceramidases with enhanced synthetic activity2015
Glycopegylated granulocyte colony stimulating factor2015
Antibody toxin conjugates2015
Methods for the purification of polypeptide conjugates comprising polyalkylene o2015
Glycopegylated erythropoietin2014